MTOR and colorectal carcinoma: In contrast, pharmacological inhibition of AATs had less significant effect on the proliferation and mTOR activation of KRAS wt CRC cell lines, Caco‐2, and Hke3‐KRASWT/WT+ (Fig. S5A–D).